EE05124B1 - Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine - Google Patents

Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine

Info

Publication number
EE05124B1
EE05124B1 EEP200200087A EEP200200087A EE05124B1 EE 05124 B1 EE05124 B1 EE 05124B1 EE P200200087 A EEP200200087 A EE P200200087A EE P200200087 A EEP200200087 A EE P200200087A EE 05124 B1 EE05124 B1 EE 05124B1
Authority
EE
Estonia
Prior art keywords
docetaxel
drate
composition
active ingredient
hepatocellular carcinoma
Prior art date
Application number
EEP200200087A
Other languages
English (en)
Estonian (et)
Inventor
Chi Chin-Wen
Lin Heng-Liang
Liu Tsung-Yun
Lui Wing-Yiu
Chau Gar-Yang
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200200087A publication Critical patent/EE200200087A/xx
Publication of EE05124B1 publication Critical patent/EE05124B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EEP200200087A 1999-08-31 2000-08-29 Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine EE05124B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920548.6A GB9920548D0 (en) 1999-08-31 1999-08-31 Treatment of hepatocellular carcinoma
PCT/EP2000/008782 WO2001015675A2 (en) 1999-08-31 2000-08-29 Use of docetaxel for treating hepatocellular carcinoma

Publications (2)

Publication Number Publication Date
EE200200087A EE200200087A (et) 2003-04-15
EE05124B1 true EE05124B1 (et) 2009-02-16

Family

ID=10860081

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200087A EE05124B1 (et) 1999-08-31 2000-08-29 Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine

Country Status (34)

Country Link
US (2) US20030158249A1 (ja)
EP (1) EP1214061B1 (ja)
JP (1) JP4866522B2 (ja)
KR (1) KR100670416B1 (ja)
CN (1) CN1174748C (ja)
AT (1) ATE269700T1 (ja)
AU (1) AU777583B2 (ja)
BG (1) BG65913B1 (ja)
BR (1) BR0013625A (ja)
CA (1) CA2382294C (ja)
CZ (1) CZ301378B6 (ja)
DE (1) DE60011794T2 (ja)
DK (1) DK1214061T3 (ja)
EA (1) EA004804B1 (ja)
EE (1) EE05124B1 (ja)
ES (1) ES2218223T3 (ja)
GB (1) GB9920548D0 (ja)
HK (1) HK1048944B (ja)
HR (1) HRP20020171A2 (ja)
HU (1) HU228861B1 (ja)
IL (2) IL147489A0 (ja)
ME (1) MEP7809A (ja)
MX (1) MXPA02002041A (ja)
NO (1) NO328527B1 (ja)
NZ (1) NZ517604A (ja)
PL (1) PL212612B1 (ja)
PT (1) PT1214061E (ja)
RS (1) RS50148B (ja)
SI (1) SI1214061T1 (ja)
SK (1) SK286378B6 (ja)
TW (1) TW589180B (ja)
UA (1) UA72927C2 (ja)
WO (1) WO2001015675A2 (ja)
ZA (1) ZA200201408B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1268619C (zh) 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
ES2325506T3 (es) * 2003-12-12 2009-09-07 Quiral Quimica Do Brasil Procedimiento para la preparacion de principios activos farmaceuticos (api) anhidros e hidratados; composiciones farmaceuticas estables preparadas a partir de los mismos y usos de dichas composiciones.
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use
BRPI0615265A8 (pt) 2005-08-31 2018-03-06 Abraxis Bioscience Llc composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
JP5368093B2 (ja) * 2005-08-31 2013-12-18 アブラクシス バイオサイエンス， エルエルシー 増大した安定性を有する難水溶性薬剤の組成物および調製の方法
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20080081051A1 (en) * 2006-09-28 2008-04-03 Robert Sabin Method of manufacturing anti-tumor and anti-viral compositions
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
FR2917088B1 (fr) * 2007-06-08 2009-09-04 Aventis Pharma Sa Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
LT2552438T (lt) 2010-03-26 2016-09-26 Abraxis Bioscience, Llc Hepatoceliulinės karcinomos gydymo būdai
BR112012028037A2 (pt) * 2010-05-03 2016-08-02 Teikoku Pharma Usa Inc formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CA2976912A1 (en) * 2015-02-17 2016-08-25 Mallinckrodt Llc Modified docetaxel liposome formulations and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
DE69324504T2 (de) * 1993-01-19 1999-08-26 Warner Lambert Co Stabilisierte, oral anzuwendende zusammensetzung enthaltend die verbindung ci-981 und verfahren
US5846945A (en) * 1993-02-16 1998-12-08 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
FR2718963B1 (fr) * 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle composition pharmaceutique à base de taxoïdes.
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US5968972A (en) 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
FR2742751B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
JP2001513078A (ja) * 1996-12-30 2001-08-28 バテル・メモリアル・インスティテュート 吸入により新生物を治療する製剤とその方法
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
HU230338B1 (hu) * 1997-06-27 2016-02-29 Abraxis Bioscience Llc Gyógyászati hatóanyagokat tartalmazó új készítmények, eljárás ilyen készítmények előállítására és alkalmazására
US6544979B1 (en) * 1997-09-18 2003-04-08 Janssen Pharmaceuticals, N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
AU1289899A (en) * 1997-10-31 1999-05-24 Arch Development Corporation Methods and compositions for regulation of 5-alpha reductase activity
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
AU2713500A (en) * 1998-12-23 2000-07-31 G.D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
BRPI0610344A2 (pt) * 2005-12-13 2016-11-29 Teva Pharma forma cristalizada do atorvastatin hemi-calcium, processo para sua preparação, produto famacêutico derivado e seu uso medicinal

Also Published As

Publication number Publication date
BR0013625A (pt) 2002-05-14
NO20020829L (no) 2002-02-20
KR20020060166A (ko) 2002-07-16
DK1214061T3 (da) 2004-11-01
EA200200313A1 (ru) 2002-08-29
ME00624B (me) 2011-12-20
MXPA02002041A (es) 2002-08-20
EP1214061A2 (en) 2002-06-19
CZ2002739A3 (cs) 2002-06-12
JP2003508427A (ja) 2003-03-04
NO20020829D0 (no) 2002-02-20
RS50148B (sr) 2009-05-06
UA72927C2 (uk) 2005-05-16
EA004804B1 (ru) 2004-08-26
BG65913B1 (bg) 2010-05-31
HUP0203197A3 (en) 2005-01-28
PL353198A1 (en) 2003-11-03
CA2382294C (en) 2008-06-03
DE60011794D1 (de) 2004-07-29
EP1214061B1 (en) 2004-06-23
MEP7809A (en) 2011-12-20
HUP0203197A2 (hu) 2003-01-28
CA2382294A1 (en) 2001-03-08
IL147489A0 (en) 2002-08-14
NZ517604A (en) 2004-04-30
BG106460A (bg) 2002-09-30
US20080045584A1 (en) 2008-02-21
ZA200201408B (en) 2003-07-30
PT1214061E (pt) 2004-09-30
SK286378B6 (sk) 2008-08-05
WO2001015675A2 (en) 2001-03-08
PL212612B1 (pl) 2012-10-31
US20030158249A1 (en) 2003-08-21
ATE269700T1 (de) 2004-07-15
AU7516800A (en) 2001-03-26
SI1214061T1 (en) 2004-12-31
HRP20020171A2 (en) 2004-02-29
AU777583B2 (en) 2004-10-21
CN1372466A (zh) 2002-10-02
CZ301378B6 (cs) 2010-02-03
KR100670416B1 (ko) 2007-01-17
GB9920548D0 (en) 1999-11-03
DE60011794T2 (de) 2005-07-14
WO2001015675A3 (en) 2001-09-20
JP4866522B2 (ja) 2012-02-01
EE200200087A (et) 2003-04-15
TW589180B (en) 2004-06-01
HU228861B1 (hu) 2013-06-28
ES2218223T3 (es) 2004-11-16
YU11402A (sh) 2005-07-19
HK1048944A1 (en) 2003-04-25
NO328527B1 (no) 2010-03-08
HK1048944B (zh) 2005-04-22
CN1174748C (zh) 2004-11-10
IL147489A (en) 2006-06-11
SK2712002A3 (en) 2002-07-02

Similar Documents

Publication Publication Date Title
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
HUP0301405A2 (hu) Fokozott oldékonyságú gyógyhatású komponenseket tartalmazó készítmények
SE0102315D0 (sv) Compounds
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
NO20034204L (no) Farmasöytiske kombinasjoner til behandling av kreft
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
CY1106319T1 (el) Τοπικη θepαπεια στη μασταλγια
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
SE0000303D0 (sv) Novel compounds
SE0203817D0 (sv) New composition
DE60023321D1 (de) Zusammensetzung gegen Coccidiose
MXPA04006269A (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150829